This inventor holds 15 USPTO granted patents and 8 published patent applications and 6 EPO patents. Top assignees: University of Pennsylvania, Ascidian Therapeutics, Inc., Centre National De La Recherche Scientifique. Active years: 2020-2026.
Company Filing History:
14 out of 2,645 
2 out of 3 
1 out of 5,383 
Years Active: 2020-2026
Title: Junwei Sun: Pioneering Ocular Disorder Treatments through Innovation
Introduction
Junwei Sun is an esteemed inventor based in Philadelphia, PA, with a remarkable portfolio of 11 patents. His innovative contributions are primarily focused on advanced methods and compositions for the treatment of ocular disorders and blinding diseases.
Latest Patents
Among his latest patents, notable works include methods and compositions for treating ocular disorders through codon-optimized nucleic acid sequences of RdCVF. These encompass recombinant viral vectors such as AAV, proviral plasmids, and expression cassettes that efficiently express these optimized sequences. Such innovative compositions are instrumental in addressing certain blinding diseases related to inappropriate expression or absence of RdCVF and RdCVFL.
Another significant patent involves nucleic acid trans-splicing molecules designed to correct mutations in the ABCA4 and CEP290 genes. These molecules provide therapeutic potential for alleviating disorders associated with these mutations, including Stargardt Disease and Leber congenital amaurosis 10 (LCA 10).
Career Highlights
Junwei Sun’s career has been distinguished by his association with prominent institutions such as the University of Pennsylvania and the Institut National de la Santé et de la Recherche Médicale. His work at these organizations has facilitated groundbreaking research and development in the field of genetic and ocular health.
Collaborations
Throughout his career, Junwei has collaborated with esteemed colleagues including Jean Bennett and Jeannette Bennicelli. Their joint efforts have significantly advanced the understanding and treatment of genetic disorders, contributing to the scientific community and patient care.
Conclusion
Junwei Sun’s relentless pursuit of innovation in the realm of ocular disorders showcases the vital intersection of science and technology. His patents not only highlight his inventive spirit but also pave the way for new treatment options that could transform the lives of individuals suffering from blinding diseases.